PAVmed
PAVM
24 hedge funds and large institutions have $6.73M invested in PAVmed in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.
333% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 3
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
111% more capital invested
Capital invested by funds: $3.2M → $6.73M (+$3.54M)
60% more funds holding
Funds holding: 15 → 24 (+9)
0.01% more ownership
Funds ownership: 0.01% → 0.02% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$791K |
| 2 |
VWM
Vigilare Wealth Management
Scottsdale,
Arizona
|
+$125K |
| 3 |
SIM
Spark Investment Management
New York
|
+$120K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$115K |
| 5 |
Morgan Stanley
New York
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$23K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$20K |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$18K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$5K |
| 5 |
LCS
Levin Capital Strategies
New York
|
-$1.64K |
PAVM Hedge Fund Activity: Q1 2020 in Review
24 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2020, worth a combined $6.73M — up 111% from $3.2M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new PAVM positions and 3 closed out — a net gain of 10 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $791K. The largest seller was UBS Group, exiting entirely with an estimated $23K sold.
- 24 institutional investors held PAVmed (PAVM) as of Q1 2020, up from 15 in Q4 2019.
- Funds reported $6.73M of PAVmed stock for Q1 2020, up 111% quarter-over-quarter.
- 13 funds opened new PAVmed positions in Q1 2020 and 3 closed out, a net change of +10 holders.
- The largest PAVmed buyer in Q1 2020 was EAM Investors, an estimated $791K added.
- The largest PAVmed seller in Q1 2020 was UBS Group, an estimated $23K sold.
Based on aggregated 13F filings for Q1 2020.